Insys Therapeutics, Inc. EBITDA Margin 2013-2019 | INSYQ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Insys Therapeutics, Inc. (INSYQ) over the last 10 years. The current EBITDA margin for Insys Therapeutics, Inc. as of March 31, 2019 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2019-03-31 | $0.07B | $-0.22B | -341.54% |
| 2018-12-31 | $0.08B | $-0.12B | -148.15% |
| 2018-09-30 | $0.10B | $-0.09B | -95.83% |
| 2018-06-30 | $0.11B | $-0.24B | -217.43% |
| 2018-03-31 | $0.13B | $-0.22B | -169.77% |
| 2017-12-31 | $0.14B | $-0.21B | -149.65% |
| 2017-09-30 | $0.17B | $-0.19B | -116.97% |
| 2017-06-30 | $0.19B | $-0.02B | -7.81% |
| 2017-03-31 | $0.22B | $0.00B | 0.46% |
| 2016-12-31 | $0.24B | $0.02B | 6.20% |
| 2016-09-30 | $0.28B | $0.05B | 17.44% |
| 2016-06-30 | $0.31B | $0.08B | 26.60% |
| 2016-03-31 | $0.32B | $0.09B | 28.17% |
| 2015-12-31 | $0.33B | $0.10B | 29.31% |
| 2015-09-30 | $0.30B | $0.08B | 26.00% |
| 2015-06-30 | $0.27B | $0.06B | 22.68% |
| 2015-03-31 | $0.25B | $0.06B | 24.90% |
| 2014-12-31 | $0.22B | $0.06B | 29.22% |
| 2014-09-30 | $0.20B | $0.07B | 33.16% |
| 2014-06-30 | $0.17B | $0.06B | 34.13% |
| 2014-03-31 | $0.13B | $0.05B | 36.15% |
| 2013-12-31 | $0.10B | $0.04B | 35.35% |
| 2013-09-30 | $0.06B | $0.01B | 18.75% |
| 2013-06-30 | $0.04B | $-0.00B | -10.00% |
| 2013-03-31 | $0.03B | $-0.02B | -60.00% |
| 2012-12-31 | $0.02B | $-0.02B | -137.50% |
